Results 161 to 170 of about 8,261 (192)

Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. [PDF]

Front Immunol
Corsini CA, Campos GRF, Martins PFDS, Filgueiras PS, Lima AES, Gomes SVC, Curimbaba CAL, Lorencini DA, Morandi Junior E, da Silva VM, Cervi MC, Borges MC, de Lima PR, do Nascimento JPR, Correa PRL, Castilho LDR, de Oliveira JG, Filho OAM, Nogueira ML, Grenfell RFQE.   +19 more
europepmc   +1 more source

Humoral immunity and infection status of PLWH following vaccination after the BA.5/BF.7 wave. [PDF]

Front Microbiol
Xie Y, Song X, Yang L, Wang L, Gao H, Zhang L, Feng Y, Chen Y, Yan H, Feng F, Dai E, Wang Y, Feng A.   +12 more
europepmc   +1 more source

Antibody Responses to SARS-CoV-2 and Common HCoVs in Hemodialysis Patients and Transplant Recipients: Data from the Dominican Republic. [PDF]

Vaccines (Basel)
Alcantara Sanchez L, Alvarez Guerra E, Li D, King SM, Hilchey SP, Zhou Q, Dewhurst S, Fiscella K, Zand MS.   +8 more
europepmc   +1 more source

Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study. [PDF]

Vaccines (Basel)
Sartori NS, Machado KLLL, Miyamoto ST, Pretti FZ, Gouveia MDPG, Oliveira YGP, da Silva VG, Faé F, Burian APN, Tapia KRL, Moulin ACS, Grillo LL, Athayde PDS, Corona HDS, Ramos SS, Peixoto FMMMC, Ribeiro PDC, Magalhães VO, de Aguiar MF, Biegelmeyer E, Kayser C, De Souza AWS, Castro CHM, Bühring J, Ribeiro SLE, Oliveira Dos Santos SH, Martins CP, da Silva Rodrigues JW, Sousa Dias MM, Dutra BG, Telles CMPF, Basualto Dias SE, de Rezende RPV, Baptista KL, Gaudio RC, de Melo AKG, da Silva VB, Cruz VA, Rêgo J, Vieira RMRA, Vieira ASR, Kakehasi AM, Tavares ACFMG, Pereira AJA, da Costa PVT, Azevedo VF, Pamplona Bueno de Andrade N, Tres GL, Assis Martins-Filho O, Peruhype-Magalhães V, Valim V, Ferreira GA, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, de Souza VA, Xavier RM, Pileggi GS, Monticielo OA, SAFER-Study Group Task Force.   +60 more
europepmc   +1 more source

Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination. [PDF]

Front Immunol
Öztürk H, Özsoy M, Tuna A, Varlibas A, Cesur S, Aksoy A, Çifci A, Demir ME.   +7 more
europepmc   +1 more source

Seroconversion Rates Following COVID-19 Vaccination in People Living with HIV: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
Alkhidir M, Sridharan K.
europepmc   +1 more source

Safety comparison of mRNA, viral vector, and inactivated Covid-19 vaccines: incidence of adverse events following primary and booster doses among medical professionals in Malaysia. [PDF]

BMC Infect Dis
Prabhu R, Prabhu G, Htay MNN, Thundakattil AV, Moe S, Das S.   +5 more
europepmc   +1 more source

Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye. [PDF]

Infect Dis Clin Microbiol
Ocaklı Aİ, Özyar-Kurtçu ŞA, Uzun M, Kaşıkçı-Çavdar M, Telli-Dizman G, Metan G, Akova M, Sarıbaş Z, Şener B.   +8 more
europepmc   +1 more source

An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey [PDF]

Journal of Medical Virology, 2022
Limited data are available on the short- to midterm levels of antibodies to the CoronaVac vaccine and quantitative change in humoral response after homologous or heterologous booster doses. In this prospective cohort study, we evaluated the anti-receptor-
Bülent Kılıç, Gül Ergör, Yücel Demiral   +2 more
exaly   +5 more sources